Related references
Note: Only part of the references are listed.A Unification of Mediation and Interaction A 4-Way Decomposition
Tyler J. VanderWeele
EPIDEMIOLOGY (2014)
Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials
JoAnn E. Manson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials
Carolyn J. Crandall et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Changing Concepts: Menopausal Hormone Therapy and Breast Cancer
Rowan T. Chlebowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Mammographic Density, Response to Hormones, and Breast Cancer Risk
Norman F. Boyd et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study
Jack Cuzick et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
How to obtain the confidence interval from a P value
Douglas G. Altman et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The impact of changes in hormone therapy on breast cancer incidence in the US population
Nathan J. Coombs et al.
CANCER CAUSES & CONTROL (2010)
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
Rowan T. Chlebowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk
Carolyn J. Crandall et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Recent trends in breast cancer incience in US white women by county-level urban/rural and poverty status
Amelia K. Hausauer et al.
BMC MEDICINE (2009)
The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence
Helena M. Verkooijen et al.
MATURITAS (2009)
Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women
Rowan T. Chlebowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy
Rowan T. Chlebowski et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Mammographic density - Measurement of mammographic density
Martin J. Yaffe
BREAST CANCER RESEARCH (2008)
The decrease in breast-cancer incidence in 2003 in the United States.
Peter M. Ravdin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Changes in US prescribing patterns of menopausal hormone therapy, 2001-2003
Esther Hing et al.
OBSTETRICS AND GYNECOLOGY (2006)
Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis
Valerie A. McCormack et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative Randomized Trial
A McTiernan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results
JS Haas et al.
ANNALS OF INTERNAL MEDICINE (2004)
National use of postmenopausal hormone therapy - Annual trends and response to recent evidence
AL Hersh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial
RT Chlebowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Effects of different types of hormone replacement therapy on mammographic density
N Colacurci et al.
MATURITAS (2001)
Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable ?
EE Sterns et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Share Paper
